BRX 3 (Rexulti 3 mg)
Generic Name: brexpiprazole
Pill with imprint BRX 3 is Purple, Round and has been identified as Rexulti 3 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd. and Lundbeck.
Rexulti is used in the treatment of major depressive disorder; schizophrenia; depression and belongs to the drug class atypical antipsychotics. Rexulti 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BRX 3
Rexulti
- Generic Name
- brexpiprazole
- Imprint
- BRX 3
- Strength
- 3 mg
- Color
- Purple
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Otsuka Pharmaceutical Co., Ltd. and Lundbeck
- National Drug Code (NDC)
- 59148-0039
- Inactive Ingredients
-
lactose monohydrate,
corn starch,
microcrystalline cellulose,
magnesium stearate,
magnesium silicate,
titanium dioxide,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about Rexulti (brexpiprazole)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (368)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: atypical antipsychotics
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.